Sign in

CIK 0001681682

  • Non-accelerated filer
  • Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
260579295
Phone
+1 734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Technology Officer sold 33,750 shares at an average $2.44 ($82,388)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chief Commercial Officer sold 20,000 shares at an average $1.08 ($21,685)
  9. 4 Open-market sale Chief Commercial Officer sold 8,731 shares at $0.94 ($8,207)
  10. 4 Open-market sale Director sold 10,000 shares at $0.90 ($9,000)
  11. 4 Open-market sale Chief Commercial Officer sold 11,269 shares at $0.94 ($10,593)
  12. 4 Open-market sale Chief Financial Officer sold 35,000 shares at $0.90 ($31,500)
  13. 4 Open-market sale Chief Commercial Officer sold 25,000 shares at $0.73 ($18,250)
  14. 4 Open-market sale Chief Executive Officer sold 71,519 shares at $0.83 ($59,361)
  15. 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.81 ($8,100)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.72 ($7,200)
  18. 4 Option exercise Director acquired 100,503 shares (option exercise)
  19. 4 Option exercise Chief Technology Officer acquired 26,000 shares (option exercise)
  20. 4 Option exercise Director acquired 5,000 shares (option exercise)

Page 4 of 9 · 174 filings